CHRONOBIOLOGICAL ASPECTS OF MELATONIN INFLUENCE ON THE SEVERAL COMPONENTS OF THE METABOLIC SYNDROME IN HYPOPINEALISM

Authors

  • Bondarenko L. O. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv
  • Mishchenko T. V. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv
  • Poltorak V. V. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv
  • Sotnyk N. M. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv

DOI:

https://doi.org/10.21856/j-PEP.2015.3.11

Keywords:

melatonin, metabolic syndrome, hypopinealism, circadian rhythm.

Abstract

It was studied the effects of melatonin administration (2,5 mg/kg b. w. intramuscularly for 10 days) on circadian rhythms of the metabolic syndrome main components parameters on young adult rabbits with metabolic syndrome on the background of hypopinealism induced by long (for 5 months) day and night lighting. It was established that chronic treatment with this indolamine induced restoration of circadian rhythms of insulin and glucose levels in serum, decrease of insulin resistance manifestations, reduce abdominal-visceral fat weight, lowering the concentration and recovery leptin circadian rhythms in the serum. It was also revealed, that melatonin administration demonstrate antihypertensive effect, but don’t restore systolic blood pressure circadian rhythm in studied rabbits.

References

Mishchenko TV, Gladkyh OI, Poltorak VV, et al. Endokrynologija 2015; 2: 494-500.

Kravec EB, Samojlova JuG, Matjusheva NB, et al. Byul Sib Med 2008; 1:80-88.

Mishchenko TV, Gladkyh OI, Poltorak VV, et al. Probl Endokryn Patologii 2015; 1:73-79.

Bondarenko LO, Sotnyk NM, Mishchenko TV. Probl Endokryn Patologii 2015; 2:85-93.

Bondarenko LA, Mishchenko TV. Patol Fiziol i Eksp Meditsina 2015; 1:46-49.

Patent 20383 UA Sposib modeljuvannja involjutyvnyh procesiv u pineal’nij zalozi.

Illnerova H, Vanecek J. Reprod Nutr Dev 1988; 28:515-526.

Matthews DR, Hosker JP, Rudenski AS, et al. Diabetologia 1985; 28:412-419.

Yang J, Wang ZL, Zhao XQ, et al. PLoS ONE 2008; 3(1):5-17.

Grant RT, Rothschild R. J Physiology 1934; 81:265-269.

Patent 83426 UA Prystrij dlja vymirjuvannja arterial’nogo tysku u kroliv.

Reiter RJ. Neuroendocrinol Lett 1988; 10(4): 218-225.

Arushanyan EB. Unikalnyiy melatonin (biologicheskie svoystva i farmakologiya), Stavropol, 2006: 400 p.

Hardeland R, Cardinali DP, Srinivasan V, et al. Progr Neurobiol 2011; 93:350-384.

Sartori C, Dessen P, Mathieu C, et al. Endocrinology 2009; 150:5311-5347.

Shatylo VV, Antonjuk-Shheglova IA, Bodak EM, et al. Krovoobig ta Gemostaz 2013; 1:5-12.

Peschke E, Schucht H, Mühlbauer E. J Pineal Res 2010; 49:373-381.

Anhe GF, Caperuto LC, Pereira-Da-Silva M, et al. J Neurochem 2004; 90:559-566.

Ha E, Yim SV, Chung JH, et al. J Pineal Res 2006; 41(1):67-72.

Bazwinsky-Wutschke I, Bieseke L, Mühlbauer E, et al. J Pineal Res 2014; 56:82-96.

Raskind MA, Burke BL, Crites NJ, et al. Neuropsychopharm 2007; 32(2):284-288.

Brydon L, Petit L, Delagrange P, et al. Endocrinology 2001; 142:4264-4271.

Alonso-Vale MI, Peres SB, Vernochet C, et al. J Pineal Res 2009; 47:221-227.

Leibowitz A, Peleg E, Sharabi Y. Amer J Hypertens 2008; 21(3):348-351.

Scheer FAJL, Van Montfrans GA, Van Someren EJW, et al. Hypertension 2004; 43:192-197.

Korkushko OV, Shatylo VB, Antonjuk-Shheglova IA, et al. Zastosuvannja melatoninu v geriatrychnij praktyci, Kyi’v, 2010: 23 p.

Downloads

Published

2021-08-17

How to Cite

Bondarenko, L. O. ., Mishchenko, T. V. ., Poltorak, V. V. ., & Sotnyk, . N. M. . (2021). CHRONOBIOLOGICAL ASPECTS OF MELATONIN INFLUENCE ON THE SEVERAL COMPONENTS OF THE METABOLIC SYNDROME IN HYPOPINEALISM. Problems of Endocrine Pathology, 53(3), 85-93. https://doi.org/10.21856/j-PEP.2015.3.11

Most read articles by the same author(s)

1 2 > >>